| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 702564 | 78802 | LEVONORGESTREL TEVA 1,5 MG COMPRIMIDO EFG | LEVONORGESTREL TEVA 1,5 MG COMPRIMIDO EFG ,1 comprimido | 1,5 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78802/78802_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78802/78802_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2014-05-30 | 1 | 1 | 1 | 2014-11-19 | 2014-11-19 | 1 | 2014-11-20 | View Edit Delete | ||||||||||||
| 701435 | 106332016 | OMNITROPE 10 MG/1,5 ML SOLUCION INYECTABLE EN CARTUCHO | OMNITROPE 10 MG/1,5 ML SOLUCION INYECTABLE EN CARTUCHO, 1 cartucho precargado de 1,5 ml (SurePal 10) | 6,7 mg/ml inyectable 1,5 ml | 12 | 1 | 57 | 1 cartucho precargado de 1,5 ml (SurePal 10) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/106332016/106332016_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/106332016/106332016_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2014-02-18 | 1 | 1 | 1 | 2014-02-18 | 2014-02-18 | 1 | 2014-05-24 | View Edit Delete | ||||||||||||
| 701437 | 106332010 | OMNITROPE 15 MG/1,5 ML SOLUCION INYECTABLE EN CARTUCHO | OMNITROPE 15 MG/1,5 ML SOLUCION INYECTABLE EN CARTUCHO, 1 cartucho precargado de 1,5 ml (SurePal 15) | 15 mg | 12 | 1 | 57 | 1 cartucho precargado de 1,5 ml (SurePal 15) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/106332010/106332010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/106332010/106332010_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2014-02-18 | 1 | 1 | 1 | 2014-02-18 | 2014-02-18 | 1 | 2015-04-13 | View Edit Delete | ||||||||||||
| 702422 | 106332013 | OMNITROPE 5 MG/1,5 ML SOLUCION INYECTABLE EN CARTUCHO | OMNITROPE 5 MG/1,5 ML SOLUCION INYECTABLE EN CARTUCHO, 1 cartucho precargado de 1,5 ml (SurePal 5) | 5 mg inyectable 1,5 ml | 12 | 1 | 57 | 1 cartucho precargado de 1,5 ml (SurePal 5) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/106332013/106332013_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/106332013/106332013_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5172 | SANDOZ FARMACEUTICA S.A. | 2014-05-28 | 1 | 1 | 1 | 2014-05-28 | 2014-05-28 | 1 | 2014-10-23 | View Edit Delete | ||||||||||||
| 703830 | 79102 | GALLIAPHARM 0,74 - 1,85 GBq GENERADOR DE RADIONUCLIDO | GALLIAPHARM 0,74 - 1,85 GBq GENERADOR DE RADIONUCLIDO ,1 generador | 0,74 - 1,85 GBq | 12 | 1 | 50 | 1 generador | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79102/79102_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79102/79102_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12588 | NUCLIBER, S.A. | 2014-12-17 | 1 | 1 | 1 | 2014-12-17 | 2015-01-15 | 0 | 2017-11-03 | View Edit Delete | ||||||||||||
| 701257 | 112812001 | BEXSERO SUSPENSION INYECTABLE EN JERINGA PRECARGADA | BEXSERO SUSPENSION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada con aguja | N/A (Vacuna) | 33 | 1 | 61 | 1 jeringa precargada con aguja | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/112812001/112812001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/112812001/112812001_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 19738 | GLAXOSMITHKLINE S.A. | 2014-01-27 | 1 | 1 | 1 | 2014-01-27 | 2014-01-27 | 1 | 2014-08-21 | View Edit Delete | ||||||||||||
| 702569 | 114922002 | INCRUSE ELLIPTA 55 mcg POLVO PARA INHALACION UNIDOSIS | INCRUSE ELLIPTA 55 mcg POLVO PARA INHALACION UNIDOSIS, 30 dosis | 55 microgramos/dosis | 37 | 1 | 30 | 30 dosis | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114922002/114922002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114922002/114922002_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30530 | GLAXOSMITHKLINE S.A. | 2014-05-30 | 1 | 1 | 1 | 2014-05-30 | 2014-05-30 | 1 | 2015-03-13 | View Edit Delete | ||||||||||||
| 702694 | 13853001 | REMSIMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | REMSIMA 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 100 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/13853001/13853001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/13853001/13853001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32858 | KERN PHARMA S.L. | 2014-06-23 | 1 | 1 | 1 | 2014-06-23 | 2014-06-23 | 1 | 2025-05-13 | View Edit Delete | ||||||||||||
| 702138 | 78692 | IODURO (123I) DE SODIO GE HEALTHCARE 37 MBQ/ML SOLUCION INYECTABLE | IODURO (123I) DE SODIO GE HEALTHCARE 37 MBQ/ML SOLUCION INYECTABLE , 1 vial de 0,5 a 10 ml | 37 MBq/ml | 45 | 1 | 34 | 1 vial de 0,5 a 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78692/78692_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78692/78692_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 10603 | GE HEALTHCARE BIO-SCIENCES, S.A.U. | 2014-04-25 | 1 | 1 | 1 | 2014-04-25 | 2014-04-25 | 1 | 2014-10-27 | View Edit Delete | ||||||||||||
| 702836 | 58931 | HIDONAC ANTIDOTO 200 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION | HIDONAC ANTIDOTO 200 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION , 1 vial de 25 ml | 5.000 mg | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58931/58931_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58931/58931_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29563 | ZAMBON S.A.U. | 1992-04-01 | 1 | 1 | 1 | 1992-04-01 | 2014-06-25 | 1 | 2014-12-01 | View Edit Delete | ||||||||||||
| 701735 | 113882001 | ABILIFY MAINTENA 300 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ABILIFY MAINTENA 300 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 300 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113882001/113882001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113882001/113882001_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2014-03-11 | 1 | 1 | 1 | 2014-03-11 | 2014-03-11 | 1 | 2014-12-10 | View Edit Delete | ||||||||||||
| 701736 | 113882002 | ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ABILIFY MAINTENA 400 MG POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 400 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/113882002/113882002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/113882002/113882002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29813 | OTSUKA PHARMACEUTICAL S.A. | 2014-03-11 | 1 | 1 | 1 | 2014-03-11 | 2014-03-11 | 1 | 2014-12-10 | View Edit Delete | ||||||||||||
| 702077 | 198067003 | MABTHERA 1400 MG SOLUCION PARA INYECCION SUBCUTANEA | MABTHERA 1400 MG SOLUCION PARA INYECCION SUBCUTANEA, 1 vial de 11,7 ml (120 mg/ml) | 1.400 mg inyectable 11,7 ml | 45 | 1 | 34 | 1 vial de 11,7 ml (120 mg/ml) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/198067003/198067003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/198067003/198067003_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2014-04-11 | 1 | 1 | 1 | 2014-04-11 | 2014-04-11 | 1 | 2015-11-02 | View Edit Delete | ||||||||||||
| 703274 | 114937001 | GAZYVARO 1000 MG CONCENTRADO PARA SOLUCION PARA PERFUSION | GAZYVARO 1000 MG CONCENTRADO PARA SOLUCION PARA PERFUSION, 40 ml | 1.000 mg inyectable 40 ml | 45 | 1 | 34 | 40 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114937001/114937001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114937001/114937001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 29096 | ROCHE FARMA S.A. | 2014-08-06 | 1 | 1 | 1 | 2014-08-06 | 2014-08-06 | 0 | 2015-10-08 | View Edit Delete | ||||||||||||
| 703889 | 79118 | CISATRACURIO SALA 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG | CISATRACURIO SALA 5 MG/ML SOLUCION INYECTABLE Y PARA PERFUSION EFG , 1 vial de 30 ml | 5 mg/ml inyectable 30 ml | 45 | 1 | 34 | 1 vial de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79118/79118_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79118/79118_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2014-10-20 | 1 | 1 | 1 | 2014-10-20 | 2014-10-20 | 0 | 2017-09-22 | View Edit Delete | ||||||||||||
| 701925 | 78613 | TEICOPLANINA ACCORD 200 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | TEICOPLANINA ACCORD 200 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial (polvo) + 1 vial de disolvente | 200 mg | 45 | 1 | 34 | 1 vial (polvo) + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78613/78613_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78613/78613_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2014-04-01 | 1 | 1 | 1 | 2014-04-01 | 2014-04-01 | 1 | 2026-03-06 | View Edit Delete | ||||||||||||
| 701926 | 78614 | TEICOPLANINA ACCORD 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | TEICOPLANINA ACCORD 400 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial (polvo) + 1 vial de disolvente | 400 mg | 45 | 1 | 34 | 1 vial (polvo) + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78614/78614_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78614/78614_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2014-04-01 | 1 | 1 | 1 | 2014-04-01 | 2014-04-01 | 1 | 2026-02-13 | View Edit Delete | ||||||||||||
| 702587 | 73266 | DOXORUBICINA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | DOXORUBICINA ACCORD 2 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 via de 50 ml | 2 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 via de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73266/73266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73266/73266_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-07-04 | 1 | 1 | 1 | 2011-07-04 | 2014-05-28 | 1 | 2014-10-15 | View Edit Delete | ||||||||||||
| 702821 | 114923001 | ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION | ENTYVIO 300 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION, 1 vial | 300 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/114923001/114923001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/114923001/114923001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 35004 | TAKEDA FARMACEUTICA ESPANA S.A. | 2014-06-30 | 1 | 1 | 1 | 2014-06-30 | 2014-06-30 | 1 | 2015-09-04 | View Edit Delete | ||||||||||||
| 703044 | 78913 | PROTHROMPLEX TOTAL 600 UI / 20 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | PROTHROMPLEX TOTAL 600 UI / 20 ML POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE ,1 vial + 1 vial de disolvente | 600 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78913/78913_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78913/78913_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16885 | TAKEDA FARMACEUTICA ESPANA S.A. | 2015-02-10 | 1 | 1 | 1 | 2015-02-10 | 2015-03-10 | 1 | 2018-02-13 | View Edit Delete |
Page 35 of 1036, showing 20 records out of 20709 total, starting on record 681, ending on 700